Finding a clinical trial or study for all types of amyloidosis in Australia
Click here for current or pending Clinical Trials in Australia.
Conducting a clinical trial is complicated. It requires cooperation between many people and organizations. These may include research sponsors, industry, pharmaceutical companies, academia, government, nonprofit organizations, clinical investigators, patients, physicians, and regulators.
Time, money, personnel, materials such as medical supplies, support systems and manpower are also essential plus a clear plan for completing the necessary steps to conduct the trial. At any point along the way to opening a trial there may be delays i.e. when an Ethics and Governance Committee want to check safety issues.
Often trials take much longer to the recruitment phase than was originally envisaged.
Even when a trial is open no one patient can be guaranteed that they will be recruited to take part. Each trial has strict inclusion and exclusion criteria as well as caps on numbers allowed to enroll.
A trial may be stopped if there are unexpected side effects or if the investigational product is not found to be of use in an “interim analysis”.
In the end it is important to know that most trials are gathering information before the true effectiveness of a drug is known and a patient may well not be “missing out” if they cannot be registered.
The AAN web site will endeavor to post on this website page when a trial for any type of amyloidosis in Australia is open for recruitment.
Most clinical trials are listed on the Australian New Zealand Clinical Trials Registry (ANZCTR).This registry has been established at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, with funding from the NHMRC and New Zealand Health Research Council.The registry lists trials that have been approved and are recruiting in the full spectrum of therapeutic areas of pharmaceuticals, surgical procedures, preventive measures, lifestyle, devices, treatment and rehabilitation strategies, and complementary therapies. Patients can also ask their treatment team or GP if they are aware of any trials that could be available and appropriate to them.
Around the world
The web site Centrewatch site gives an overview of some of the trials and studies being conducted for most types of amyloidosis around the world.
Although most of these trials are not available in Australia, Australian patients may in the long run benefit from the results of many of them as they add to the knowledge about diagnosing and treating all types of amyloidosis.